Xcout Intel
Gero
Gero is a biotechnology company headquartered in Singapore with a U.S. subsidiary, combining physics, biology, and artificial intelligence to decode human biology and develop life-changing medicines.
Subscribe to see Gero’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Gero at a glance
Gero is a drug discovery company headquartered in Singapore. It has raised at least $23M across the 2 funding rounds on record. Its most recent funding round, Series A extension, raised $17M in June 2026. Xcout tracks 6 named people at Gero, including Aleksandr Sviridov (Chief Operating Officer).
Gero leadership
- Aleksandr SviridovChief Operating Officer
- Peter Fedichevco-founder and CEO
- Max KholinCo-founder, Chief Corporate Development Officer
- Maxim Kholinco-founder
- Brian KennedyIndependent Director
- Yuri MelnichekBoard Member
Gero funding rounds
At least $23M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A extension | $17M | 3 named | |
| Series A | $6M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Gero competitors
A few of Gero's closest competitors — see the full list of competitors and alternatives →
Generare is a biotechnology and artificial intelligence company headquartered in Paris, France, focused on commercial bioprospecting and decoding natural products.
Cassidy Bio is an AI-first biotechnology company founded in 2024 and based in Israel that is developing a programmable platform for gene editing. The company utilizes a genomic foundation model powered by artificial intelligence to design safer and more scalable gene editing therapies across various guides, editors, and delivery contexts.
Automera is an early-stage biotechnology research company headquartered in Singapore. The company focuses on the development of novel therapeutics through autophagy-based targeted protein degradation.
Ochre Bio is a biotechnology company developing precision medicines for chronic liver diseases. It uses data from human donor livers, computational biology, and experimental models to identify and validate therapeutic targets for pharmaceutical and biotechnology development.
QurieGen is a precision medicine company headquartered in Nijmegen, Netherlands, that uses single-cell AI to transform drug development and create treatments more efficiently.
Retro Biosciences is a biotechnology research company based in Redwood City, California, that develops therapies targeting aging biology. Its goal is to extend healthy human lifespan by 10 years.
Get Gero's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Gero in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access